 | • レポートコード：D0GIR-00451 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫疾患治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫疾患治療の種類別市場規模（ブリッジセラピー、組み換え技術、糞便細菌療法、造血幹細胞移植、光線療法、駆虫療法、活性化誘発アッセイ、飛行時間型質量分析サイトメトリー）、用途別市場規模（全身性自己免疫疾患、限局性自己免疫疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Sanofi、Johnson & Johnson、Roche Diagnostics、AstraZeneca、Siemens Healthcare、Pfizer、GlaxoSmithKline、Boehringer Ingelheim、Merck ・地域別グローバル市場分析 2015年-2020年 ・自己免疫疾患治療の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫疾患治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫疾患治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫疾患治療の南米市場（ブラジル、アルゼンチン） ・自己免疫疾患治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ブリッジセラピー、組み換え技術、糞便細菌療法、造血幹細胞移植、光線療法、駆虫療法、活性化誘発アッセイ、飛行時間型質量分析サイトメトリー ・用途別分析：全身性自己免疫疾患、限局性自己免疫疾患 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Autoimmune Disorders Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Autoimmune Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Autoimmune Disorders Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autoimmune Disorders Treatment market has been segmented into:
Bridge therapy
Recombinant technology
Fecal bacteriotherapy
Hematopoietic stem-cell transplantation
Phototherapy
Helminthic therapy
Activation-induced assays
Cytometry by time-of-flight mass spectrometry
By Application, Autoimmune Disorders Treatment has been segmented into:
Systemic autoimmune diseases
Localized autoimmune diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autoimmune Disorders Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Autoimmune Disorders Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autoimmune Disorders Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Autoimmune Disorders Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Autoimmune Disorders Treatment Market Share Analysis
Autoimmune Disorders Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autoimmune Disorders Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autoimmune Disorders Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Autoimmune Disorders Treatment are:
Abbott Laboratories
Sanofi
Johnson & Johnson
Roche Diagnostics
AstraZeneca
Siemens Healthcare
Pfizer
GlaxoSmithKline
Boehringer Ingelheim
Merck
Table of Contents
1 Autoimmune Disorders Treatment Market Overview
1.1 Product Overview and Scope of Autoimmune Disorders Treatment
1.2 Classification of Autoimmune Disorders Treatment by Type
1.2.1 Global Autoimmune Disorders Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autoimmune Disorders Treatment Revenue Market Share by Type in 2019
1.2.3 Bridge therapy
1.2.4 Recombinant technology
1.2.5 Fecal bacteriotherapy
1.2.6 Hematopoietic stem-cell transplantation
1.2.7 Phototherapy
1.2.8 Helminthic therapy
1.2.9 Activation-induced assays
1.2.10 Cytometry by time-of-flight mass spectrometry
1.3 Global Autoimmune Disorders Treatment Market by Application
1.3.1 Overview: Global Autoimmune Disorders Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Systemic autoimmune diseases
1.3.3 Localized autoimmune diseases
1.4 Global Autoimmune Disorders Treatment Market by Regions
1.4.1 Global Autoimmune Disorders Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autoimmune Disorders Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autoimmune Disorders Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autoimmune Disorders Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Disorders Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autoimmune Disorders Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Disorders Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Diagnostics
2.4.1 Roche Diagnostics Details
2.4.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche Diagnostics SWOT Analysis
2.4.4 Roche Diagnostics Product and Services
2.4.5 Roche Diagnostics Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens Healthcare SWOT Analysis
2.6.4 Siemens Healthcare Product and Services
2.6.5 Siemens Healthcare Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autoimmune Disorders Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autoimmune Disorders Treatment Players Market Share
3.2.2 Top 10 Autoimmune Disorders Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autoimmune Disorders Treatment Revenue and Market Share by Regions
4.2 North America Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
5 North America Autoimmune Disorders Treatment Revenue by Countries
5.1 North America Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
5.2 USA Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
6 Europe Autoimmune Disorders Treatment Revenue by Countries
6.1 Europe Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
6.2 Germany Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
6.4 France Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autoimmune Disorders Treatment Revenue by Countries
7.1 Asia-Pacific Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
7.2 China Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
7.5 India Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
8 South America Autoimmune Disorders Treatment Revenue by Countries
8.1 South America Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
8.2 Brazil Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autoimmune Disorders Treatment by Countries
9.1 Middle East & Africa Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autoimmune Disorders Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Autoimmune Disorders Treatment Market Forecast by Type (2019-2024)
10.3 Bridge therapy Revenue Growth Rate (2015-2025)
10.4 Recombinant technology Revenue Growth Rate (2015-2025)
10.5 Fecal bacteriotherapy Revenue Growth Rate (2015-2025)
10.6 Hematopoietic stem-cell transplantation Revenue Growth Rate (2015-2025)
10.7 Phototherapy Revenue Growth Rate (2015-2025)
10.8 Helminthic therapy Revenue Growth Rate (2015-2025)
10.9 Activation-induced assays Revenue Growth Rate (2015-2025)
10.10 Cytometry by time-of-flight mass spectrometry Revenue Growth Rate (2015-2025)
11 Global Autoimmune Disorders Treatment Market Segment by Application
11.1 Global Autoimmune Disorders Treatment Revenue Market Share by Application (2015-2020)
11.2 Autoimmune Disorders Treatment Market Forecast by Application (2019-2024)
11.3 Systemic autoimmune diseases Revenue Growth (2015-2020)
11.4 Localized autoimmune diseases Revenue Growth (2015-2020)
12 Global Autoimmune Disorders Treatment Market Size Forecast (2021-2025)
12.1 Global Autoimmune Disorders Treatment Market Size Forecast (2021-2025)
12.2 Global Autoimmune Disorders Treatment Market Forecast by Regions (2021-2025)
12.3 North America Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
12.6 South America Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Autoimmune Disorders Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autoimmune Disorders Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autoimmune Disorders Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autoimmune Disorders Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Autoimmune Disorders Treatment Major Business
Table 7. Abbott Laboratories Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Autoimmune Disorders Treatment Product and Solutions
Table 10. Abbott Laboratories Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Autoimmune Disorders Treatment Major Business
Table 13. Sanofi Autoimmune Disorders Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Autoimmune Disorders Treatment Product and Solutions
Table 16. Sanofi Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Autoimmune Disorders Treatment Major Business
Table 19. Johnson & Johnson Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Autoimmune Disorders Treatment Product and Solutions
Table 22. Johnson & Johnson Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Diagnostics Corporate Information, Location and Competitors
Table 24. Roche Diagnostics Autoimmune Disorders Treatment Major Business
Table 25. Roche Diagnostics Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Roche Diagnostics SWOT Analysis
Table 27. Roche Diagnostics Autoimmune Disorders Treatment Product and Solutions
Table 28. Roche Diagnostics Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AstraZeneca Corporate Information, Location and Competitors
Table 30. AstraZeneca Autoimmune Disorders Treatment Major Business
Table 31. AstraZeneca Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 32. AstraZeneca SWOT Analysis
Table 33. AstraZeneca Autoimmune Disorders Treatment Product and Solutions
Table 34. AstraZeneca Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Siemens Healthcare Corporate Information, Location and Competitors
Table 36. Siemens Healthcare Autoimmune Disorders Treatment Major Business
Table 37. Siemens Healthcare Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Siemens Healthcare SWOT Analysis
Table 39. Siemens Healthcare Autoimmune Disorders Treatment Product and Solutions
Table 40. Siemens Healthcare Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Autoimmune Disorders Treatment Major Business
Table 43. Pfizer Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Autoimmune Disorders Treatment Product and Solutions
Table 46. Pfizer Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GlaxoSmithKline Corporate Information, Location and Competitors
Table 48. GlaxoSmithKline Autoimmune Disorders Treatment Major Business
Table 49. GlaxoSmithKline Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 50. GlaxoSmithKline SWOT Analysis
Table 51. GlaxoSmithKline Autoimmune Disorders Treatment Product and Solutions
Table 52. GlaxoSmithKline Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 54. Boehringer Ingelheim Autoimmune Disorders Treatment Major Business
Table 55. Boehringer Ingelheim Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Boehringer Ingelheim SWOT Analysis
Table 57. Boehringer Ingelheim Autoimmune Disorders Treatment Product and Solutions
Table 58. Boehringer Ingelheim Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck Corporate Information, Location and Competitors
Table 60. Merck Autoimmune Disorders Treatment Major Business
Table 61. Merck Autoimmune Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Merck SWOT Analysis
Table 63. Merck Autoimmune Disorders Treatment Product and Solutions
Table 64. Merck Autoimmune Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Autoimmune Disorders Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Autoimmune Disorders Treatment Revenue Share by Players (2015-2020)
Table 67. Global Autoimmune Disorders Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Autoimmune Disorders Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
Table 70. North America Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Autoimmune Disorders Treatment Revenue by Countries (2015-2020)
Table 74. South America Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Autoimmune Disorders Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Autoimmune Disorders Treatment Revenue Share by Type (2015-2020)
Table 79. Global Autoimmune Disorders Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Autoimmune Disorders Treatment Revenue by Application (2015-2020)
Table 81. Global Autoimmune Disorders Treatment Revenue Share by Application (2015-2020)
Table 82. Global Autoimmune Disorders Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Autoimmune Disorders Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autoimmune Disorders Treatment Picture
Figure 2. Global Autoimmune Disorders Treatment Revenue Market Share by Type in 2019
Figure 3. Bridge therapy Picture
Figure 4. Recombinant technology Picture
Figure 5. Fecal bacteriotherapy Picture
Figure 6. Hematopoietic stem-cell transplantation Picture
Figure 7. Phototherapy Picture
Figure 8. Helminthic therapy Picture
Figure 9. Activation-induced assays Picture
Figure 10. Cytometry by time-of-flight mass spectrometry Picture
Figure 11. Autoimmune Disorders Treatment Revenue Market Share by Application in 2019
Figure 12. Systemic autoimmune diseases Picture
Figure 13. Localized autoimmune diseases Picture
Figure 14. Global Autoimmune Disorders Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Autoimmune Disorders Treatment Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Autoimmune Disorders Treatment Revenue Market Share in 2019
Figure 23. Global Top 10 Players Autoimmune Disorders Treatment Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Autoimmune Disorders Treatment Revenue Market Share by Regions (2015-2020)
Figure 27. Global Autoimmune Disorders Treatment Revenue Market Share by Regions in 2018
Figure 28. North America Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Europe Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 31. South America Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 33. North America Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. North America Autoimmune Disorders Treatment Revenue Market Share by Countries in 2019
Figure 35. USA Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Canada Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Europe Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Autoimmune Disorders Treatment Revenue Market Share by Countries in 2019
Figure 40. Germany Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 41. UK Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 42. France Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Russia Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Italy Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Autoimmune Disorders Treatment Revenue Market Share by Countries in 2019
Figure 47. China Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Japan Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Korea Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 50. India Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 52. South America Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. South America Autoimmune Disorders Treatment Revenue Market Share by Countries in 2019
Figure 54. Brazil Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 59. UAE Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 62. Global Autoimmune Disorders Treatment Revenue Share by Type (2015-2020)
Figure 63. Global Autoimmune Disorders Treatment Revenue Share by Type in 2019
Figure 64. Global Autoimmune Disorders Treatment Market Share Forecast by Type (2021-2025)
Figure 65. Global Bridge therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Recombinant technology Revenue Growth Rate (2015-2020)
Figure 67. Global Fecal bacteriotherapy Revenue Growth Rate (2015-2020)
Figure 68. Global Hematopoietic stem-cell transplantation Revenue Growth Rate (2015-2020)
Figure 69. Global Phototherapy Revenue Growth Rate (2015-2020)
Figure 70. Global Helminthic therapy Revenue Growth Rate (2015-2020)
Figure 71. Global Activation-induced assays Revenue Growth Rate (2015-2020)
Figure 72. Global Cytometry by time-of-flight mass spectrometry Revenue Growth Rate (2015-2020)
Figure 73. Global Autoimmune Disorders Treatment Revenue Share by Application (2015-2020)
Figure 74. Global Autoimmune Disorders Treatment Revenue Share by Application in 2019
Figure 75. Global Autoimmune Disorders Treatment Market Share Forecast by Application (2021-2025)
Figure 76. Global Systemic autoimmune diseases Revenue Growth Rate (2015-2020)
Figure 77. Global Localized autoimmune diseases Revenue Growth Rate (2015-2020)
Figure 78. Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Autoimmune Disorders Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Autoimmune Disorders Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 82. Europe Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 84. South America Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Autoimmune Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ミトコンドリア障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Mitochondrial Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 尿素サイクル障害（UCD）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Urea Cycle Disorders (UCD) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- 進行性運動失調症・筋力低下症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Treatment for Syndromes of Progressive Ataxia and Weakness Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and g…
- 膝及び腰疾患の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Knee & Hip Disorders market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Knee & Hip Disorders mar…
- 自己免疫治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Autoimmune Drugs market repo…